Medusind Solutions, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Medusind Solutions, Inc. - overview
Established
2002
Location
Miami, FL, US
Primary Industry
Healthcare IT
About
Medusind Solutions, Inc. is a revenue cycle management company based in the US, specializing in tailored solutions for healthcare and dental practices to streamline operations and enhance financial performance. Founded in 2002, Medusind Solutions, Inc. is headquartered in Miami, US.
The company provides comprehensive revenue cycle management services, focusing on medical billing, coding, and credentialing. The current CEOs are Amit Chandani, Jose Rivero, and Vipul Bansal. In January 2023, Alpine Investors acquired Medusind from H. I.
G. Capital, strengthening its market position. The company has engaged in two deals to date, with its most recent deal occurring on January 12, 2023. Medusind specializes in comprehensive revenue cycle management (RCM) solutions for medical and dental practices.
Their services include end-to-end RCM, medical billing, medical coding, dental billing, credentialing, and business process outsourcing. Their proprietary software, MedClarity, optimizes claims processing, eligibility verification, and financial reporting, catering to a diverse array of medical specialties and dental service organizations across the US and select international markets. Medusind generates revenue through partnerships and service agreements with healthcare providers, including hospitals and clinics. The company operates on a B2B model, providing RCM services on a contractual basis, where clients pay for customized solutions based on their operational needs.
Revenue is accumulated from various service lines such as medical billing and coding, typically secured through multi-year contracts that foster long-term client relationships. Pricing structures align with the client's scale and complexity, focusing on maximizing profitability for healthcare professionals. Following its acquisition in January 2023, Medusind aims to leverage its enhanced market position to propel growth and improve efficiency for its clients. The company is exploring the introduction of new product offerings, although specific release dates are not disclosed.
Additionally, it plans to expand its reach into new geographic markets, targeting regions that align with its services. The recent acquisition will support these initiatives by enabling Medusind to accelerate growth and enhance profitability for its clients.
Current Investors
Alpine Investors
Primary Industry
Healthcare IT
Sub Industries
Healthcare IT, Analytics & Performance Software
Website
www.medusind.com
Verticals
Cloud Computing, HealthTech
Company Stage
Mature - Buyout
Total Amount Raised
Subscriber access only
Medusind Solutions, Inc. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Add-on | Completed | edgeMED Healthcare, LLC | - | ||||||||
| Add-on, Trade Sale | Completed | Billing Solutions LLC | - | ||||||||
| Secondary Buyout | Completed | Medusind Solutions, Inc. | - | ||||||||
| Add-on | Completed | Revenue Cycle Management Agreements of RC McLean and Associates, Inc. | - | ||||||||
| Secondary Buyout | Completed | Medusind Solutions, Inc. | - |
Displaying 1 - 5 of 5

Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.